FDA Clears CoAlign Innovations’ AccuLIF Interbody Fusion Devices to Market

Redwood City, Calif.-based CoAlign Innovations received FDA market clearance for the AccuLIF XL lateral expandable interbody fusion device line.

Advertisement

The product line includes the AccuLIF TL for TLIF procedures and the AccuLIF PL for PLIF procedures. The systems are designed to be low profile with controlled expansion for precise anatomical reconstruction.

More Articles on Devices:
Smith & Nephew Allowed to Promote KFx Medical Rotator Cuff Repair Device
Australian Government Warns of LMT Surgical’s Arthroplasty Device Safety
Stryker Awarded $85.5M DOD Contract for Hip, Knee Implants

Advertisement

Next Up in Spinal Tech

  • Zavation Medical has acquired ChoiceSpine, and Derek Kuyper will be CEO of the combined company, according to a Feb. 26…

  • Carlsmed saw significant gains in fourth-quarter and 2025 revenue, according to financial results posted Feb. 25. Five things to know:…

Advertisement

Comments are closed.